[1] |
Gregg AR, Skotko BG, Benkendorf JL, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics[J]. Genet Med, 2016, 18(10):1056-1065. doi: 10.1038/gim.2016.97.
pmid: 27467454
|
[2] |
陈丽媛, 徐咏, 王辉, 等. 无创产前筛查高风险病例的临床特征及影响因素分析[J]. 实用医学杂志, 2020, 36(16):2285-2289, 2294. doi: 10.3969/j.issn.1006-5725.2020.16.023.
|
[3] |
杨岚, 肖建平, 王念怡, 等. NIPS在染色体非整倍体及微重复微缺失综合征筛查中的应用分析[J]. 现代妇产科进展, 2022, 31(11):848-851. doi: 10.13283/j.cnki.xdfckjz.2022.11.008.
|
[4] |
钟艳娟, 卢建, 陈剑虹, 等. 无创DNA产前检测在胎儿染色体非整倍体疾病及染色体拷贝数变异筛查中的研究[J]. 现代医药卫生, 2022, 38(3):494-497. doi: 10.3969/j.issn.1009-5519.2022.03.034.
|
[5] |
郑芸芸, 万陕宁, 宋婷婷, 等. 8 594例孕妇无创DNA产前检测在胎儿染色体非整倍体疾病筛查中的临床应用[J]. 实用妇产科杂志, 2019, 35(1):68-71.
|
[6] |
Yuan X, Yong W, Dai L, et al. The role of non-invasive prenatal testing and ultrasound in prenatal screening of fetal chromosomal abnormalities in singleton: a retrospective study[J]. Ann Transl Med, 2023, 11(2):111. doi: 10.21037/atm-22-6343.
pmid: 36819517
|
[7] |
Gardner RJM, Sutherland GR, Shaffer LG. Chromosome Abnormalities and Genetic Counseling[M]. 4th ed. Oxford University Press, 2012:439-485.
|
[8] |
谢潇潇, 赵青冬, 胡凌云, 等. 非侵入性产前检测对胎儿罕见染色体三体的检测价值[J]. 南方医科大学学报, 2023, 43(12):2071-2077. doi: 10.12122/j.issn.1673-4254.2023.12.11.
|
[9] |
张苗苗, 方玉琴, 李景然, 等. 85525例无创产前检测发现罕见常染色体三体结果分析[J]. 实用医学杂志, 2023, 39(12):1506-1511. doi: 10.3969/j.issn.1006-5725.2023.12.008.
|
[10] |
Del Gaudio D, Shinawi M, Astbury C, et al. Diagnostic testing for uniparental disomy: a points to consider statement from the American College of Medical Genetics and Genomics (ACMG)[J]. Genet Med, 2020, 22(7):1133-1141. doi: 10.1038/s41436-020-0782-9.
pmid: 32296163
|
[11] |
Lannoo L, van Straaten K, Breckpot J, et al. Rare autosomal trisomies detected by non-invasive prenatal testing: an overview of current knowledge[J]. Eur J Hum Genet, 2022, 30(12):1323-1330. doi: 10.1038/s41431-022-01147-1.
pmid: 35896702
|
[12] |
Pertile MD, Halks-Miller M, Flowers N, et al. Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease[J]. Sci Transl Med, 2017, 9(405):eaan1240. doi: 10.1126/scitranslmed.aan1240.
|
[13] |
Wolstenholme J. Confined placental mosaicism for trisomies 2, 3, 7, 8, 9, 16, and 22: their incidence, likely origins, and mechanisms for cell lineage compartmentalization[J]. Prenat Diagn, 1996, 16(6):511-524. doi: 10.1002/(SICI)1097-0223(199606)16:6<511::AID-PD904>3.0.CO;2-8.
|
[14] |
Dungan JS, Klugman S, Darilek S, et al. Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)[J]. Genet Med, 2023, 25(2):100336. doi: 10.1016/j.gim.2022.11.004.
|
[15] |
翟秀璋, 卢庆, 赖春慧, 等. 无创产前检测技术对胎儿染色体拷贝数变异检测的临床意义[J]. 检验医学与临床, 2022, 19(8):1070-1074. doi: 10.3969/j.issn.1672-9455.2022.08.015.
|
[16] |
Grati FR, Molina Gomes D, Ferreira JC, et al. Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies[J]. Prenat Diagn, 2015, 35(8):801-809. doi: 10.1002/pd.4613.
|
[17] |
Dar P, Jacobsson B, Clifton R, et al. Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome[J]. Am J Obstet Gynecol, 2022, 227(1):79.e1-e11. doi: 10.1016/j.ajog.2022.01.002.
|
[18] |
Xue H, Yu A, Lin M, et al. Efficiency of expanded noninvasive prenatal testing in the detection of fetal subchromosomal microdeletion and microduplication in a cohort of 31,256 single pregnancies[J]. Sci Rep, 2022, 12(1):19750. doi: 10.1038/s41598-022-24337-9.
pmid: 36396840
|
[19] |
冯暄, 张庆华, 王兴, 等. 扩展性无创产前筛查技术在染色体拷贝数变异检测中的临床应用效果评价[J]. 检验医学, 2023, 38(8):730-737. doi: 10.3969/j.issn.1673-8640.2023.08.005.
|
[20] |
Lu Y, Zuo N, Ning M, et al. Limited ability of increased sequencing depth in detecting cases missed by noninvasive prenatal testing: a comparative analysis of 3 clinical cases[J]. Sci Rep, 2024, 14(1):2304. doi: 10.1038/s41598-024-52767-0.
|